Dozens of widely prescribed medications can change how your bladder stores or releases urine, and the effects range from mild inconvenience to serious tissue damage. The bladder relies on a complex web of nerve signals and chemical messengers running from the brain through the spinal cord to the pelvic floor, and drugs that act on any part of that network can throw things off. Some medications tighten the outlet so you cannot empty properly; others relax it so you leak. A few can inflame or even permanently scar the bladder lining. Understanding which drugs carry these risks, and why, puts you in a much better position to recognize symptoms early and talk to your doctor about alternatives.
Medications That Make It Hard to Empty Your Bladder
Urinary retention occurs when the bladder cannot fully empty. It can feel like straining at the toilet, producing only a weak stream, or sensing that something is still left afterward. In severe cases, you cannot urinate at all, which is a medical emergency. Several drug classes are known triggers.
Anticholinergic medications are among the most common culprits. These drugs block acetylcholine, a chemical messenger that tells the bladder muscle to squeeze. The bladder muscle depends heavily on acetylcholine to contract, so blocking it weakens the force needed to push urine out. The heart-rhythm drug disopyramide, for instance, has been shown in laboratory studies to inhibit bladder muscle contractions specifically through this anticholinergic mechanism, and clinical reports have linked it to urinary retention.1PubMed. Effects of disopyramide on detrusor muscle contraction: in vitro experiment and report of 3 cases with disopyramide-induced urinary retention Disopyramide is not the only offender. Older antihistamines like diphenhydramine, certain antidepressants such as amitriptyline, and antipsychotics with strong anticholinergic properties all work through the same basic pathway.
Decongestants pose a different but equally real risk. Pseudoephedrine, the active ingredient in many over-the-counter cold and sinus products, stimulates receptors in the bladder neck and urethra that cause those muscles to tighten. At the same time, it activates receptors in the bladder wall that promote relaxation of the storage muscle. The combination creates a double whammy: the exit clenches shut while the bladder itself becomes less able to generate the pressure needed to overcome the resistance.2PubMed Central. Voiding dysfunction in patients with nasal congestion treated with pseudoephedrine: a prospective study This problem is especially pronounced in older men with enlarged prostates, where the outlet is already partially obstructed.
Medications That Cause Leaking or Urgency
On the opposite end of the spectrum, some drugs make the bladder overactive or weaken the muscles that keep urine in, leading to leakage, sudden urgency, or frequent trips to the bathroom.
Diuretics, commonly prescribed for high blood pressure and heart failure, are a frequent source of bladder complaints. They work by forcing the kidneys to produce more urine. That rapid filling can overwhelm an aging bladder and trigger involuntary contractions of the bladder muscle, adding urgency on top of simple frequency.3PubMed Central. Association of diuretic use and overactive bladder syndrome in older adults: a propensity score analysis People taking loop diuretics like furosemide sometimes find that the urgency hits so fast they cannot reach a bathroom in time, particularly in the hours right after a dose.
Alpha-blockers, used for hypertension and prostate enlargement, can cause stress urinary incontinence in some people. These drugs relax smooth muscle throughout the body, including the urethra. In women, loss of urethral tone from an alpha-blocker like doxazosin has been documented as a direct cause of stress incontinence, where leaking occurs with coughing, sneezing, or lifting.4PubMed. Stress urinary incontinence due to prescription medications: alpha-blockers and angiotensin converting enzyme inhibitors Switching to a different class of blood-pressure medication resolved the problem in reported cases.
Cholinesterase inhibitors, prescribed for Alzheimer’s disease and other dementias, work by boosting acetylcholine levels in the brain to improve memory and cognition. But acetylcholine also acts on the bladder. In one clinical series, roughly 7 out of 94 patients treated with donepezil developed urinary incontinence, though it was transient in most cases.5PubMed. Urinary incontinence: an unrecognised adverse effect with donepezil Broader research has confirmed that cholinesterase inhibitors as a class are associated with overactive bladder symptoms.6PubMed. Risk of overactive bladder associated with cholinesterase inhibitors in dementia
When Drugs Directly Damage Bladder Tissue
Some medications go beyond altering nerve signals and actually injure the bladder’s inner lining. This is a different category of harm: not a functional glitch but structural damage that can be painful and, in some cases, permanent.
Cyclophosphamide, a chemotherapy drug used for cancers and severe autoimmune diseases, is the textbook example. As the body breaks it down, one of its byproducts, acrolein, accumulates in urine and directly attacks the urothelium, the protective cell layer that lines the bladder. This can cause hemorrhagic cystitis, a condition involving inflammation, bleeding, and severe pain during urination. Research has shown that the damage unfolds in waves: an early burst of cell death that occurs independently of acrolein, followed by a later wave that is largely driven by it.7PubMed Central. Cyclophosphamide Induces an Early Wave of Acrolein-Independent Apoptosis in the Urothelium Protective strategies exist for this problem, which we will return to below.
Ketamine, used medically as an anesthetic and increasingly misused recreationally, presents a growing concern. Long-term or heavy ketamine use causes what is sometimes called ketamine-induced cystitis. Symptoms typically begin with bladder irritation and progress to severe urinary frequency, urgency, pain with a full bladder, and incontinence. Ketamine metabolites trigger intense inflammation of the bladder lining, break down its protective barrier, promote blood-vessel damage, and eventually cause the bladder wall to stiffen with scar tissue (fibrosis).8PubMed Central. Pathophysiology, clinical presentation, and management of ketamine-induced cystitis In severe cases, patients develop ulcerative cystitis and drastically reduced bladder capacity, sometimes holding only a fraction of normal urine volume.9PubMed Central. Illicit ketamine and its bladder consequences: is it irreversible? The damage tends to affect young people because recreational ketamine use skews toward younger age groups. Whether the damage is fully reversible once ketamine use stops remains an open question; some patients improve, but those with advanced fibrosis face lasting problems.10PubMed Central. Ketamine-Induced Cystitis: A Comprehensive Review of the Urologic Effects of This Psychoactive Drug
Bladder Cancer Risk and Pioglitazone
Beyond acute symptoms and tissue damage, at least one widely used medication has drawn scrutiny for a possible link to bladder cancer. Pioglitazone, a diabetes drug in the thiazolidinedione class, has been debated for years. A large meta-analysis pooling data from 19 studies found that people who had ever used pioglitazone had a modestly elevated risk of bladder cancer compared with those who never used it. The risk appeared to climb with longer use: people who took the drug for more than two years showed a meaningfully higher risk than short-term users, and a similar pattern held for higher cumulative doses.11PubMed Central. Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis A large population-based cohort study found a similar duration-and-dose-dependent increase in bladder cancer risk among pioglitazone users.12BMJ. Pioglitazone use and risk of bladder cancer: population based cohort study
The picture is not entirely settled, though. A separate large study using a fully adjusted model found no statistically significant association between pioglitazone use and bladder cancer, and no dose or duration trend.13JAMA. Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes The conflicting results may reflect differences in study populations, follow-up periods, and how confounders were handled. Regulatory agencies in several countries have responded by adding warnings to pioglitazone labels and, in some cases, restricting its use in patients with a history of bladder cancer. If you take pioglitazone and are concerned, a conversation with your prescriber about the duration of your use and your individual risk factors is worthwhile.
Diabetes Drugs That Raise Urinary Tract Infection Risk
SGLT-2 inhibitors are a newer class of diabetes medications, including drugs like empagliflozin, dapagliflozin, and canagliflozin. They lower blood sugar by blocking sugar reabsorption in the kidneys, which means extra glucose gets flushed out in the urine. That glucose-rich urine creates a more hospitable environment for bacteria, and studies have found that SGLT-2 inhibitor use is a significant predictor of urinary tract infections in people with type 2 diabetes.14PubMed Central. Association of SGLT-2 inhibitors with bacterial urinary tract infection in type 2 diabetes Genital fungal infections (yeast infections) are also more common for the same reason. The heart and kidney benefits of SGLT-2 inhibitors are substantial enough that most patients and doctors accept these risks, but staying hydrated and recognizing early symptoms of a UTI can help prevent complications.
Psychiatric Medications and the Bladder
Several psychiatric medications have unexpected bladder effects that often catch patients off guard. Serotonergic antidepressants, including SSRIs and SNRIs, have been linked to urinary incontinence in case reports, possibly through serotonin receptors located on the bladder wall.15PubMed. Serotonergic antidepressants and urinary incontinence The irony is that duloxetine, an SNRI, is actually used in some countries specifically to treat stress incontinence, because the balance of serotonin and norepinephrine effects on the urethral sphincter can go either way depending on the drug and the patient.
Lithium, a mood stabilizer used for bipolar disorder, has also been associated with urgency incontinence. In one series, roughly one in six women taking lithium developed significant urinary or urgency incontinence. The proposed mechanism involves lithium disrupting the normal balance between the nerve signals that contract and relax the bladder. In those cases, symptoms improved when anticholinergic medications were added, lithium doses were lowered, or both.16PubMed. Treatment-emergent incontinence with lithium
Why Older Adults Face Higher Risk
Aging itself changes bladder function: the muscle becomes less elastic, nerve signals slow down, and many older adults already have some degree of overactive bladder or incomplete emptying. Layer multiple medications on top of that baseline vulnerability, and problems multiply quickly.
Polypharmacy is the central issue. Older adults are more likely to take several drugs that each carry a small anticholinergic effect. Individually, any one of those drugs might not cause noticeable bladder symptoms. Together, their combined anticholinergic burden adds up. A study of older Turkish women found that those with high cumulative anticholinergic burden were significantly more likely to experience nocturia (waking at night to urinate), independent of age, other medical conditions, and lab values.17PubMed. A High Anticholinergic Burden Is Independently Associated With Nocturia in Turkish Older Women That study also found that the nocturia group had higher rates of falls, depression, and functional decline, suggesting the bladder symptoms are not just an inconvenience but part of a broader pattern of drug-related harm in frail older adults.
Older men with benign prostatic enlargement face a particular danger. Their urethra is already partially squeezed by the growing prostate, so any medication that further tightens the outlet or weakens the bladder’s squeezing ability can tip them into acute urinary retention. This is one reason pharmacists and emergency departments see spikes in catheterizations during cold and flu season, when older men reach for pseudoephedrine-based decongestants without realizing the risk.
The Prescribing Cascade Problem
One of the trickiest aspects of drug-induced bladder problems is that they are often misdiagnosed as a new, separate condition rather than recognized as a side effect. This leads to what researchers call a prescribing cascade: drug A causes a symptom, the symptom is treated with drug B, and drug B carries its own side effects. The result is more medications and more risk with each step.
The cholinesterase inhibitor cascade is a well-studied example. A patient with dementia starts donepezil to help with cognition. The donepezil boosts acetylcholine levels, which causes the bladder to become overactive. Instead of recognizing the incontinence as a side effect, the doctor prescribes an antimuscarinic drug (like oxybutynin) to treat the overactive bladder. But antimuscarinics block acetylcholine in the brain as well, directly undermining the cognitive benefit the cholinesterase inhibitor was providing in the first place. Worse, the combination has been linked to increased risk of delirium and falls in people living with dementia.6PubMed. Risk of overactive bladder associated with cholinesterase inhibitors in dementia Avoiding this cascade requires clinicians to ask a simple question whenever a new bladder symptom appears: could any of this patient’s current medications be causing it?
Children, ADHD Medications, and Bedwetting
Medication effects on the bladder are not limited to adults. In children, ADHD stimulant medications like methylphenidate have a complicated relationship with bedwetting (nocturnal enuresis). Some evidence suggests stimulants can actually help resolve bedwetting, possibly by lowering sleep arousal thresholds so children wake up when their bladder is full. Case reports describe children whose bedwetting stopped immediately after starting a stimulant, only to return when the medication was paused.18PubMed Central. Optimising the management of children with concomitant bladder dysfunction and behavioural disorders
Confusingly, there are also reports of the opposite: methylphenidate triggering new-onset bedwetting in a child who had no prior history of it. In one documented case, an 8-year-old developed nocturnal enuresis shortly after starting methylphenidate. The bedwetting stopped when the drug was discontinued, returned when it was restarted, and resolved again with discontinuation, strongly suggesting a causal link.19Zahedan Journal of Research in Medical Sciences. Nocturnal Enuresis Due to Methylphenidate Consumption The proposed mechanism here is different: the stimulant may enhance the urination reflex itself. Parents and pediatricians should be aware that both outcomes are possible, and any change in a child’s continence after starting or adjusting ADHD medication deserves attention rather than dismissal.
Protecting the Bladder During Chemotherapy
For patients receiving cyclophosphamide or its relative ifosfamide, bladder protection is a routine part of treatment planning. The drug mesna (short for 2-mercaptoethane sulfonate sodium) works by binding to acrolein, the toxic metabolite, in the urine before it can attack the bladder lining. Mesna is converted to an inactive form in the bloodstream and then reactivated by the kidneys, so it arrives in the bladder ready to neutralize the threat without interfering with the cancer-killing action of the chemotherapy itself.20PubMed. Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis In a study of 22 patients who had already developed hemorrhagic cystitis from cyclophosphamide, mesna prevented recurrence in all but one patient across a total of 68 treatment cycles.
Aggressive hydration is the other pillar of prevention. Keeping urine dilute and flowing rapidly reduces the concentration and contact time of toxic metabolites against the bladder wall. A randomized trial comparing mesna to aggressive intravenous hydration in bone marrow transplant patients receiving high-dose cyclophosphamide found both approaches equally effective at preventing hemorrhagic cystitis.21PubMed. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation In practice, many oncology protocols use both together.22PubMed. Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy
BCG Therapy and Bladder Irritation
Not every drug that affects the bladder reaches it through the bloodstream. Bacillus Calmette-Guérin (BCG) is a live bacterial preparation instilled directly into the bladder to treat certain types of early-stage bladder cancer. It works by provoking a strong local immune response that helps destroy residual cancer cells. The tradeoff is that the immune reaction also targets normal bladder tissue. Bladder irritation, general malaise, and fever are very common side effects, while severe complications remain rare.23PubMed Central. Managing the adverse events of intravesical bacillus Calmette-Guérin therapy Patients undergoing BCG therapy typically experience urgency, frequency, and burning for a day or two after each instillation, and these symptoms generally lessen with time and supportive care. Knowing that this bladder irritation is expected and self-limiting helps patients stick with a treatment that has strong evidence for preventing cancer recurrence.